NICE guidance on panobinostat for patients with multiple myeloma after at least two previous treatments.
| Autor: | Hall CJ; National Institute for Health and Care Excellence, Manchester M1 4BT, UK. Electronic address: caroline.hall@nice.org.uk., Doss S; National Institute for Health and Care Excellence, Manchester M1 4BT, UK., Hay N; National Institute for Health and Care Excellence, Manchester M1 4BT, UK., Sutcliffe F; National Institute for Health and Care Excellence, Manchester M1 4BT, UK., Stevens A; National Institute for Health and Care Excellence, Manchester M1 4BT, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Lancet. Oncology [Lancet Oncol] 2016 Mar; Vol. 17 (3), pp. 279-80. Date of Electronic Publication: 2016 Jan 27. |
| DOI: | 10.1016/S1470-2045(16)00061-9 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|